Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

CAE (CAE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

CAE (CAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CAEPositive Net Change SKYHPositive Net Change

Zacks Equity Research

Epsilon Energy Ltd. (EPSN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Epsilon Energy (EPSN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EPSNPositive Net Change

Zacks Equity Research

Analysts Estimate Fidelis Insurance Holdings (FIHL) to Report a Decline in Earnings: What to Look Out for

Fidelis Insurance (FIHL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FIHLPositive Net Change

Zacks Equity Research

Performance Food Group (PFGC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Performance Food (PFGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PFGCNegative Net Change

Zacks Equity Research

Analysts Estimate XCel Brands (XELB) to Report a Decline in Earnings: What to Look Out for

XCel Brands (XELB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XELBNegative Net Change ONONPositive Net Change

Zacks Equity Research

Alithya Group (ALYAF) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Alithya (ALYAF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALYAFNegative Net Change

Zacks Equity Research

Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy?

ABSCI CORP (ABSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ABSIPositive Net Change IMNMNegative Net Change

Zacks Equity Research

Earnings Preview: AST SpaceMobile, Inc. (ASTS) Q2 Earnings Expected to Decline

AST SpaceMobile (ASTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ASTSNegative Net Change

Zacks Equity Research

Coherent (COHR) Reports Next Week: Wall Street Expects Earnings Growth

Coherent (COHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COHRPositive Net Change BITFNegative Net Change

Zacks Equity Research

CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Q2 Release

CorMedix (CRMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRMDNegative Net Change KYMRNegative Net Change

Zacks Equity Research

Will ESS Tech, Inc. (GWH) Report Negative Q2 Earnings? What You Should Know

ESS Tech (GWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GWHPositive Net Change PLUGPositive Net Change

Zacks Equity Research

Marex Group PLC (MRX) Earnings Expected to Grow: Should You Buy?

Marex Group PLC (MRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MRXNegative Net Change HIVENegative Net Change

Zacks Equity Research

North American Construction (NOA) Reports Next Week: Wall Street Expects Earnings Growth

North American Construction (NOA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NOAPositive Net Change

Zacks Equity Research

Earnings Preview: QXO, Inc. (QXO) Q2 Earnings Expected to Decline

QXO INC (QXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

QXONegative Net Change

Zacks Equity Research

Stantec (STN) Earnings Expected to Grow: Should You Buy?

Stantec (STN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STNPositive Net Change

Zacks Equity Research

Earnings Preview: DLocal (DLO) Q2 Earnings Expected to Decline

DLocal (DLO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DLOPositive Net Change

Zacks Equity Research

Earnings Preview: Drilling Tools International Corp. (DTI) Q2 Earnings Expected to Decline

Drilling Tools International Corp. (DTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DTINegative Net Change

Zacks Equity Research

Brinker International (EAT) Earnings Expected to Grow: Should You Buy?

Brinker International (EAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EATNegative Net Change WENPositive Net Change

Zacks Equity Research

Compared to Estimates, Dine Brands (DIN) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Dine Brands (DIN) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

DINNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 60.18% Upside in Thryv (THRY): Here's What You Should Know

The mean of analysts' price targets for Thryv (THRY) points to a 60.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

THRYNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 29.42% Upside in TTM (TTMI): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 29.4% in TTM (TTMI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

TTMIPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 152.4% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

APGENegative Net Change

Zacks Equity Research

Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 145.8% in Pharming Group (PHAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

PHARPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe Turtle Beach (TBCH) Could Rally 25.7%: Here's is How to Trade

The mean of analysts' price targets for Turtle Beach (TBCH) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

TBCHPositive Net Change

Zacks Equity Research

Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q2 Earnings

The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

RPRXPositive Net Change